卒中后缺损复发:临床与影像表型、触发因素及危险因素
本研究回顾性分析2000至2015年麻省总医院153例卒中后复发(PSR)患者,发现PSR多发生于卒中后平均3.9年,持续18.4小时,常由感染、低血压等触发,并与女性、糖尿病等血管危险因素相关。
要点
- PSR表现为卒中后局灶缺损短暂复发,影像无新发梗死,需排除TIA和癫痫。
- 常见触发因素包括感染、低血压、低钠血症、失眠或压力及苯二氮䓬类药物使用。
- PSR患者中女性、非裔美国人、糖尿病、血脂异常、吸烟者更多,初始NIHSS评分更差。
核心结论
- PSR特征有助于快速诊断并与TIA、偏头痛、Todd麻痹和Uhthoff现象鉴别。
研究设计与样本
- 回顾性交叉队列研究识别触发因素,病例对照研究识别危险因素,纳入153例PSR患者。
主要发现
- PSR发生于卒中后平均3.9年,持续平均18.4小时,69%的发作在1天内缓解。
- 缺损通常突然且轻微,影响运动感觉或语言功能,NIHSS评分平均恶化2.5分。
- 感染、低血压、低钠血症、失眠或压力及苯二氮䓬类药物使用在PSR入院时更常见。
- 与对照组相比,PSR组女性、非裔美国人、糖尿病、血脂异常、吸烟者更多,初始NIHSS评分更差。
- 6例(4%)接受静脉tPA治疗,无并发症。
关键数值与推荐
- PSR诊断标准:卒中后局灶缺损短暂恶化或复发,MRI显示陈旧卒中无急性梗死或出血,无TIA或癫痫证据,DWI无急性病灶,无临床或脑电图癫痫证据。
临床怎么用
- 临床遇卒中后短暂局灶缺损复发,应评估触发因素如感染、低血压、低钠血症等,并排除TIA和癫痫。
局限性
- 回顾性研究,需前瞻性研究验证诊断标准和机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Reemergence of previous stroke-related deficits (or poststroke recrudescence [PSR]) is an underrecognized and inadequately characterized phenomenon. OBJECTIVE: To investigate the clinical features, triggers, and risk factors for PSR. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study incorporated a crossover cohort study to identify triggers and a case-control study to identify risk factors. The study used the Massachusetts General Hospital Research Patient Data Repository to identify patients for the period January 1, 2000, to November 30, 2015, who had a primary or secondary diagnosis of cerebrovascular disease, who underwent magnetic resonance imaging of the brain at least once, and whose inpatient or outpatient clinician note or discharge summary stated the term recrudescence. In all, 153 patients met the preliminary diagnostic criteria for PSR: transient worsening of residual poststroke focal neurologic deficits or transient recurrence of prior stroke-related focal deficits, admission magnetic resonance imaging showing a chronic stroke but no acute infarct or hemorrhage, no evidence of transient ischemic attack or seizure, no acute lesion on diffusion-weighted imaging, and no clinical or electroencephalographic evidence of seizure around the time of the event. MAIN OUTCOMES AND MEASURES: Clinical and imaging features of PSR; triggers (identified by comparing PSR admissions with adjacent admissions without PSR); and risk factors (identified by comparing PSR cases with control cases from the Massachusetts General Hospital Stroke Registry). RESULTS: Of the 153 patients, 145 had prior infarct, 8 had hypertensive brain hemorrhage, and 164 admissions for PSR were identified. The patients' mean (SD) age was 67 (16) years, and 92 (60%) were women. Recrudescence occurred a mean (SD) of 3.9 (0.6) years after the stroke, lasted 18.4 (20.4) hours, and was resolved on day 1 for 91 of the 131 episodes with documented resolution time (69%). Deficits were typically abrupt and mild and affected motor-sensory or language function. No patient had isolated gaze paresis, hemianopia, or neglect. During PSR, the National Institutes of Health Stroke Scale (NIHSS) score worsened by a mean (SD) 2.5 (1.9) points, and deficits were limited to a single NIHSS item in 62 episodes (38%). The underlying chronic strokes were variably sized, predominantly affected white matter tracts, and involved the middle cerebral artery territory for 112 patients (73%). Infection, hypotension, hyponatremia, insomnia or stress, and benzodiazepine use were higher during PSR admissions. Compared with the control group (patients who did not experience recrudescence), the PSR group (patients who were hospitalized for recrudescence) had more women, African American individuals, and those who self-identified as being from "other" race. The PSR group also had more diabetes, dyslipidemia, smoking, infarcts from small-vessel disease, and "other definite" causes and worse onset NIHSS scores. Six patients (4%) received intravenous tissue plasminogen activator without complications. CONCLUSIONS AND RELEVANCE: The PSR features identified in the study should enable prompt diagnosis and distinguish recrudescence from mimics, such as transient ischemic attacks, migraine, Todd paralysis, and Uhthoff phenomenon. Prospective studies are required to validate the proposed diagnostic criteria and to decipher underlying mechanisms.
引用
- Topcuoglu MA, Saka E, Silverman SB, et al. Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors. JAMA Neurol. 2017. PMID: 28783808. doi:10.1001/jamaneurol.2017.1668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。